1. Home
  2. IONQ vs ROIV Comparison

IONQ vs ROIV Comparison

Compare IONQ & ROIV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo IonQ Inc.

IONQ

IonQ Inc.

HOLD

Current Price

$46.83

Market Cap

16.3B

Sector

Industrials

ML Signal

HOLD

Logo Roivant Sciences Ltd.

ROIV

Roivant Sciences Ltd.

HOLD

Current Price

$21.91

Market Cap

14.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IONQ
ROIV
Founded
2015
2014
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Wholesale Distributors
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
16.3B
14.1B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
IONQ
ROIV
Price
$46.83
$21.91
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
14
8
Target Price
$68.57
$24.31
AVG Volume (30 Days)
19.7M
7.9M
Earning Date
11-05-2025
11-10-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$79,836,000.00
$20,329,000.00
Revenue This Year
$148.30
N/A
Revenue Next Year
$78.94
$376.94
P/E Ratio
N/A
N/A
Revenue Growth
113.07
N/A
52 Week Low
$17.88
$8.73
52 Week High
$84.64
$23.47

Technical Indicators

Market Signals
Indicator
IONQ
ROIV
Relative Strength Index (RSI) 43.75 58.99
Support Level $45.92 $20.14
Resistance Level $52.15 $23.47
Average True Range (ATR) 3.77 0.86
MACD -0.06 0.08
Stochastic Oscillator 14.22 54.42

Price Performance

Historical Comparison
IONQ
ROIV

About IONQ IonQ Inc.

IonQ Inc sells access to several quantum computers of various qubit capacities and is in the process of researching and developing technologies for quantum computers with increasing computational capabilities. The company currently makes access to its quantum computers available via cloud platforms and also to select customers via its own cloud service. This cloud-based approach enables the broad availability of quantum-computing-as-a-service (QCaaS). The company derives its revenue from its quantum-computing-as-a-service arrangements, consulting services related to co-developing algorithms on company's quantum computing systems and contracts associated with the design, development, and construction of specialized quantum computing systems together with related services.

About ROIV Roivant Sciences Ltd.

Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.

Share on Social Networks: